Recombinant cytomegalovirus vectors as vaccines for tuberculosis
US-11091775-B2 · Aug 17, 2021 · US
This page is not indexed by search engines while we improve data quality.
Aeras patents
Aeras holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 0 |
| First publication | Jan 18, 2018 |
| Latest publication | Aug 17, 2021 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Recombinant Mycobacterium Encoding A Heparin-Binding Hemagglutinin (HBHA) Fusion Protein And Uses Thereof
US-2018305416-A1 · Oct 25, 2018 · US
Recombinant mycobacterium encoding a heparin-binding hemagglutinin (HBHA) fusion protein and uses thereof
US-9926346-B2 · Mar 27, 2018 · US
Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis
US-2018016599-A1 · Jan 18, 2018 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Recombinant cytomegalovirus vectors as vaccines for tuberculosis
US-11091775-B2 · Aug 17, 2021 · US
Recombinant Mycobacterium Encoding A Heparin-Binding Hemagglutinin (HBHA) Fusion Protein And Uses Thereof
US-2018305416-A1 · Oct 25, 2018 · US
Recombinant mycobacterium encoding a heparin-binding hemagglutinin (HBHA) fusion protein and uses thereof
US-9926346-B2 · Mar 27, 2018 · US
Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis
US-2018016599-A1 · Jan 18, 2018 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |
| Physics | 2 |